CRx-119

DB05688ExperimentalSmall molecule

CRx-119 is a novel synergistic combination drug candidate discovered using the CombinatoRx combination High Throughput Screening (cHTS(TM)) technology with potential therapeutic use in a broad range of immuno-inflammatory conditions. CRx-119... CRx-119 is a combination of a low dose of the steroid prednisolone, 3mg, and amoxapine.

Mechanism
Curator reviewed
Primary indication
Investigated for use/treatment in periodontal disease and rheumatoid arthritis.Curator reviewed
Code names
CRx-119

Resolves to

What you can answer from here — as of April 02, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above

Which drugs share a target with CRx-119, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account